Michael Kauffman Insider Trading for June 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Kauffman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Michael Kauffman for June 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26 2020 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Option Exercise | A | 5.60 | 8,896 | 49,818 | 8,896 | |
| Jun 24 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,500 | 248 | 8,924 | |
| Jun 24 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 20.00 | 7,500 | 150,000 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Jun 24 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| Jun 18 2020 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | A | 1.77 | 25,000 | 44,250 | 25,000 | |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 357 | 12 | 0 | |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,143 | 236 | 16,424 | |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.20 | 357 | 5,783 | 756,489 | 756.8 K to 756.5 K (-0.05 %) |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 357 | 12 | 756,846 | 756.5 K to 756.8 K (+0.05 %) |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.38 | 7,143 | 116,996 | 756,489 | 763.6 K to 756.5 K (-0.94 %) |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,143 | 236 | 763,632 | 756.5 K to 763.6 K (+0.94 %) |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 7,500 | 35,640 | 385,303 | |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 7,500 | 35,640 | 341,061 | |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.50 | 7,500 | 138,746 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 7,500 | 35,640 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.13 | 7,500 | 135,944 | 555,122 | 562.6 K to 555.1 K (-1.33 %) |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 7,500 | 35,640 | 562,622 | 555.1 K to 562.6 K (+1.35 %) |